National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 1) (Cth)
PB 9 of 2023
National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 1)
I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 30 January 2023
NIKOLAI TSYGANOV
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name........................................................................................................................................ 1
2 Commencement........................................................................................................................ 1
3 Authority.................................................................................................................................. 1
4 Schedules................................................................................................................................. 1
Schedule 1—Amendments 2
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 1).
This instrument may also be cited as PB 9 of 2023.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 February 2023 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
Schedule 1- entry for Duloxetine
Omit
| Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Cymbalta | 28 | 3.86 | 15.95 |
| Capsule 60 mg (as hydrochloride) | Oral | Cymbalta | 28 | 4.38 | 13.99 |
Substitute
| Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Cymbalta | 28 | 3.86 | 18.15 |
| Capsule 60 mg (as hydrochloride) | Oral | Cymbalta | 28 | 4:38 | 18.64 |
Schedule 1 - entry for Esomeprazole and clarithromycin and amoxicillin
Omit
| Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral | Nexium Hp7 | 1 | 23.65 | 26.98 |
Substitute
| Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral | Nexium Hp7 | 1 | 23.65 | 28.26 |
Schedule 1 - after entry for Furosemide
Insert:
| Glatiramer | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled pen | Injection | Copaxone | 12 | 584.71 | 591.79 |
Schedule 1 - after entry for Lisinopril
Insert
| Macrogol 3350 | Sachets containing powder for oral solution 13.125 g with electrolytes, 30 | Oral | Movicol | 1 | 7.04 | 9.01 |
Schedule 1 - entry for Modafinil
Omit
| Modafinil | Tablet 100 mg | Oral | Modavigil | 60 | 72.13 | 76.20 |
Substitute
| Modafinil | Tablet 100 mg | Oral | Modavigil | 60 | 72.13 | 78.33 |
Schedule 1 - entry for Olanzapine
Omit
| Olanzapine | Tablet 2.5 mg | Oral | Zyprexa | 28 | 3.08 | 10.53 |
| Tablet 5 mg | Oral | Zyprexa | 28 | 4.00 | 9.84 | |
| Tablet 7.5 mg | Oral | Zyprexa | 28 | 5.67 | 11.13 | |
| Tablet 10 mg | Oral | Zyprexa | 28 | 7.55 | 13.00 | |
| Wafer 5 mg | Oral | Zyprexa Zydis | 28 | 4.00 | 9.84 | |
| Wafer 10 mg | Oral | Zyprexa Zydis | 28 | 7.55 | 13.00 | |
| Wafer 15 mg | Oral | Zyprexa Zydis | 28 | 11.33 | 16.79 | |
| Wafer 20 mg | Oral | Zyprexa Zydis | 28 | 15.11 | 20.57 |
Substitute
| Olanzapine | Tablet 2.5 mg | Oral | Zyprexa | 28 | 3.08 | 10.53 |
| Tablet 5 mg | Oral | Zyprexa | 28 | 4.00 | 13.56 | |
| Tablet 7.5 mg | Oral | Zyprexa | 28 | 5.67 | 11.13 | |
| Tablet 10 mg | Oral | Zyprexa | 28 | 7.55 | 13.00 | |
| Wafer 5 mg | Oral | Zyprexa Zydis | 28 | 4.00 | 13.56 | |
| Wafer 10 mg | Oral | Zyprexa Zydis | 28 | 7.55 | 18.58 | |
| Wafer 15 mg | Oral | Zyprexa Zydis | 28 | 11.33 | 24.23 | |
| Wafer 20 mg | Oral | Zyprexa Zydis | 28 | 15.11 | 28.01 |
Schedule 1 - entry for Salbutamol
Omit
| Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 | |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth | Asmol CFC‑Free with dose counter | 1 | 4.92 | 6.82 | |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth | Ventolin CFC‑Free with dose counter | 1 | 4.92 | 6.82 |
Substitute
| Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 | |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth | Asmol CFC‑Free with dose counter | 1 | 4.92 | 6.82 | |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth | Ventolin CFC‑Free with dose counter | 1 | 4.92 | 7.25 |
Schedule 1 - entry for Sumatriptan
Omit
| Sumatriptan | Tablet 50 mg (as succinate) | Oral | Imigran | 2 | 2.90 | 4.85 |
| 4 | 9.70 | |||||
| Tablet (fast disintegrating) 50 mg (as succinate) | Oral | Imigran FDT | 2 | 2.90 | 4.85 | |
| 4 | 9.70 |
Substitute
| Sumatriptan | Tablet 50 mg (as succinate) | Oral | Imigran | 2 | 2.90 | 4.85 |
| 4 | 9.70 | |||||
| Tablet (fast disintegrating) 50 mg (as succinate) | Oral | Imigran FDT | 4 | 9.70 |
0
0
0